《盈警響號》升華蘭德(08106.HK)料中期虧損擴大至1,094萬人幣
升華蘭德(08106.HK)發盈警,預期截至今年6月底止中期,虧損由上年同期316.9萬元人民幣,擴大至1,093.7萬元人民幣。
主因中國爆發了「新冠肺炎病毒」疫情,由此產生在多個城市採取的防疫措施、春節假期後恢復工作的延期以及中國有關當局施加的其他工作限制,導致本集團提供智慧城市解決方案業務的項目開發工作效率下降。該業務分部由於受「新冠肺炎病毒」疫情影響,各項目實施進度推進較預期緩慢;且上半年在建項目與去年同期相比較少。故該業務分部收入同比大幅下降,因而導致分部虧損大幅上升。
董事會相信有關虧損對集團之業務運營並無重大不利影響,集團維持穩健的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.